PT Phapros TbkISX:PEHA +0.78%74 FCF Margin % is 16.16% as of Mar. 2026, which is 53% above its 10-year median of 10.57. GuruFocus rates ISX:PEHA with a GF Score™ of 74/100 and a GF Value™ of Rp385.70 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 958 Drug Manufacturers companies, PT Phapros Tbk ranks better than 86.43% on this metric.
The historical rank and industry rank for PT Phapros Tbk's FCF Margin % or its related term are showing as below:
ISX:PEHA'
s FCF Margin % Range Over the Past 10 Years
Min: -19.64 Med: 10.57 Max: 23.59
Current: 18.21
During the past 13 years, the highest FCF Margin % of PT Phapros Tbk was 23.59%. The lowest was -19.64%. And the median was 10.57%.
ISX:PEHA's FCF Margin % is ranked better than 86.43% of 958
companies
in the Drug Manufacturers industry
Industry Median: 2.445
vs ISX:PEHA: 18.21
PT Phapros Tbk FCF Margin % Related Terms
PT Phapros Tbk FCF Margin % Historical Data
* Premium members only.
The historical data trend for PT Phapros Tbk's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ISX:PEHA vs ZTS, UTHR, VTRS: FCF Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, PT Phapros Tbk's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Phapros Tbk FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, PT Phapros Tbk's FCF Margin % distribution charts can be found below:
* The bar in red indicates where PT Phapros Tbk's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Phapros Tbk (ISX:PEHA) has a FCF Margin % of 16.16% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on PT Phapros Tbk and its competitors. This is 53% above median its historical median of 10.57. According to the industry distribution chart, PT Phapros Tbk ranks #130 out of 958 companies in the Drug Manufacturers industry, placing it in the top 13.6%.
Is PT Phapros Tbk's FCF Margin % too high?
PT Phapros Tbk's current FCF Margin % of 16.16% is 53% above median its 10-year median of 10.57. The Drug Manufacturers industry median FCF Margin % is 2.45. PT Phapros Tbk's value of 16.16% is 560.9% above this industry median. Based on the distribution chart, PT Phapros Tbk ranks #130 out of 958 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, PT Phapros Tbk has a GF Score™ of 74/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does PT Phapros Tbk's FCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, PT Phapros Tbk ranks #130 out of 958 companies for FCF Margin %. This places PT Phapros Tbk in the top 14% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 2.45. PT Phapros Tbk's value of 16.16% is 560.9% above this benchmark. While the company's 10-year median is 10.57 vs. the industry median of 2.45, PT Phapros Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.45, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Phapros Tbk's current FCF Margin % of 16.16% is 560.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on PT Phapros Tbk and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Phapros Tbk's current FCF Margin % is 16.16%, which is 53% above median its own 10-year median of 10.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Phapros Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Phapros Tbk (ISX:PEHA) is currently considered Possible Value Trap. The stock's GF Value™ is Rp385.70, compared to a current price of Rp260.00 — trading 32.6% below its estimated fair value. The current FCF Margin % is 16.16%, which is 53% above median its 10-year median of 10.57 and 560.9% above the Drug Manufacturers industry median of 2.45. PT Phapros Tbk's overall GF Score™ is 74/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For PT Phapros Tbk (ISX:PEHA), the current FCF Margin % is 16.16% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Phapros Tbk (ISX:PEHA) Overvalued in 2026?
Based on GuruFocus' analysis, PT Phapros Tbk stock appears to be undervalued.
The current stock price of Rp260.00 is trading 32.6% below its estimated GF Value™ of Rp385.70.
GuruFocus considers PT Phapros Tbk to be Possible Value Trap.
Key valuation signals for ISX:PEHA:
FCF Margin %: 16.16% (53% above median its 10-year median of 10.57)
GF Value™: Rp385.70 vs. price of Rp260.00 (32.6% below fair value)
Industry Position: 560.9% above the Drug Manufacturers median (#130 of 958)
No single metric tells the full story. See the ISX:PEHA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Phapros Tbk is a pharmaceutical company in Indonesia. The company is engaged in the industrial/manufacturing sector by producing and/or trading medicines, health instruments, chemical goods, and other similar goods in import, export, and other kinds of industry. The company operates through Over Counter (OTC), Ethical, Generic Drugs Bearing (OGB), and Toll Manufacturing segments. It derives maximum revenue from OGB segment.
74GF Score
Get the complete analysis for ISX:PEHA
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:PEHA has been successfully added to your 
